Logo image of DEX.CA

ALMADEX MINERALS LTD/NEW (DEX.CA) Stock Fundamental Analysis

TSX-V:DEX - TSX Venture Exchange - CA02028L1076 - Common Stock - Currency: CAD

0.415  +0.01 (+1.22%)

Fundamental Rating

4

Overall DEX gets a fundamental rating of 4 out of 10. We evaluated DEX against 798 industry peers in the Metals & Mining industry. DEX has a great financial health rating, but its profitability evaluates not so good. DEX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year DEX was profitable.
In the past year DEX has reported a negative cash flow from operations.
In multiple years DEX reported negative net income over the last 5 years.
In multiple years DEX reported negative operating cash flow during the last 5 years.
DEX.CA Yearly Net Income VS EBIT VS OCF VS FCFDEX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.10%, DEX belongs to the top of the industry, outperforming 91.48% of the companies in the same industry.
DEX has a better Return On Equity (7.20%) than 90.10% of its industry peers.
Industry RankSector Rank
ROA 7.1%
ROE 7.2%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DEX.CA Yearly ROA, ROE, ROICDEX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

DEX's Profit Margin of 191.67% is amongst the best of the industry. DEX outperforms 99.37% of its industry peers.
In the last couple of years the Profit Margin of DEX has declined.
The Operating Margin and Gross Margin are not available for DEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 191.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.31%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DEX.CA Yearly Profit, Operating, Gross MarginsDEX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

More info and screens

8

2. Health

2.1 Basic Checks

DEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for DEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DEX.CA Yearly Shares OutstandingDEX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
DEX.CA Yearly Total Debt VS Total AssetsDEX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 39.11 indicates that DEX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 39.11, DEX belongs to the top of the industry, outperforming 84.96% of the companies in the same industry.
DEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 39.11
ROIC/WACCN/A
WACC8.56%
DEX.CA Yearly LT Debt VS Equity VS FCFDEX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

DEX has a Current Ratio of 35.83. This indicates that DEX is financially healthy and has no problem in meeting its short term obligations.
DEX has a Current ratio of 35.83. This is amongst the best in the industry. DEX outperforms 96.37% of its industry peers.
DEX has a Quick Ratio of 35.83. This indicates that DEX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 35.83, DEX belongs to the top of the industry, outperforming 96.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 35.83
Quick Ratio 35.83
DEX.CA Yearly Current Assets VS Current LiabilitesDEX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 173.77% over the past year.
The earnings per share for DEX have been decreasing by -45.14% on average. This is quite bad
Looking at the last year, DEX shows a very negative growth in Revenue. The Revenue has decreased by -38.37% in the last year.
Measured over the past years, DEX shows a decrease in Revenue. The Revenue has been decreasing by -0.27% on average per year.
EPS 1Y (TTM)173.77%
EPS 3Y-45.14%
EPS 5YN/A
EPS Q2Q%183.72%
Revenue 1Y (TTM)-38.37%
Revenue growth 3Y-36.57%
Revenue growth 5Y-0.27%
Sales Q2Q%-43.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DEX.CA Yearly Revenue VS EstimatesDEX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.83, which indicates a correct valuation of DEX.
Based on the Price/Earnings ratio, DEX is valued cheaply inside the industry as 93.61% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.48. DEX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.83
Fwd PE N/A
DEX.CA Price Earnings VS Forward Price EarningsDEX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DEX.CA Per share dataDEX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALMADEX MINERALS LTD/NEW

TSX-V:DEX (8/8/2025, 7:00:00 PM)

0.415

+0.01 (+1.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst Owners15.1%
Inst Owner ChangeN/A
Ins Owners6.68%
Ins Owner ChangeN/A
Market Cap25.32M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.83
Fwd PE N/A
P/S 24.25
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)0.03
EY7.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.02
BVpS0.46
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.1%
ROE 7.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 191.67%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.31%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1735.66%
Cap/Sales 271.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 35.83
Quick Ratio 35.83
Altman-Z 39.11
F-Score5
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)1059.33%
Cap/Depr(5y)766.14%
Cap/Sales(3y)125.05%
Cap/Sales(5y)91.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.77%
EPS 3Y-45.14%
EPS 5YN/A
EPS Q2Q%183.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.37%
Revenue growth 3Y-36.57%
Revenue growth 5Y-0.27%
Sales Q2Q%-43.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-50.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.73%
OCF growth 3YN/A
OCF growth 5YN/A